s20098 has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chanmanee, T; Govitrapong, P; Tocharus, C; Tocharus, J; Wongpun, J | 1 |
| Frydman-Marom, A; Laudon, M | 1 |
1 review(s) available for s20098 and Neurodegenerative Diseases
| Article | Year |
|---|---|
Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
Topics: Acetamides; Animals; Benzofurans; Clinical Trials as Topic; Cyclopropanes; Humans; Hypnotics and Sedatives; Indenes; Melatonin; Neurodegenerative Diseases; Receptors, Melatonin; Sleep Wake Disorders | 2014 |
1 other study(ies) available for s20098 and Neurodegenerative Diseases
| Article | Year |
|---|---|
The effects of agomelatine on endoplasmic reticulum stress related to mitochondrial dysfunction in hippocampus of aging rat model.
Topics: Acetamides; Aging; Animals; Apoptosis; Calcium; Endoplasmic Reticulum Stress; Galactose; Hippocampus; Male; Matrix Metalloproteinase 9; Memory, Short-Term; Mitochondria; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptor, Melatonin, MT1 | 2022 |